- 如果營收成長率小於推銷費用成長率, 可能代表產品需要很多的促銷才能賣掉, 或是產品有問題需要花額外的推銷成本來善後
- 發展品牌的公司不樂見推銷費用率的下滑, 對此類型公司推銷費用率等同於走技術類型公司的研發費用率
| 營收淨額 QoQ YoY | 推銷費用 QoQ YoY | 管理費用 QoQ YoY | 研發費 QoQ YoY | 推銷費用率(%) QoQ YoY | 管理費用率(%) QoQ YoY | 研發費用率(%) QoQ YoY | 員工人數 QoQ YoY | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24Q4 (20) | 14.55 | 2.25 | 9.32 | 1.42 | 73.17 | 105.8 | 0.97 | 18.29 | 40.58 | 0.95 | 14.46 | -3.06 | 9.76 | 69.36 | 88.26 | 6.67 | 15.69 | 28.6 | 6.53 | 11.94 | -11.32 | 564 | 0.0 | 0.0 |
| 24Q3 (19) | 14.23 | 8.13 | -5.76 | 0.82 | 0.0 | -3.53 | 0.82 | 5.13 | 2.5 | 0.83 | 2.47 | 7.79 | 5.76 | -7.52 | 2.37 | 5.76 | -2.78 | 8.77 | 5.83 | -5.24 | 14.38 | 564 | 0.0 | 0.0 |
| 24Q2 (18) | 13.16 | 33.47 | -14.49 | 0.82 | 30.16 | -17.17 | 0.78 | -3.7 | -12.36 | 0.81 | -11.96 | -7.95 | 6.23 | -2.48 | -3.14 | 5.93 | -27.85 | 2.49 | 6.16 | -34.03 | 7.64 | 564 | 0.0 | 0.0 |
| 24Q1 (17) | 9.86 | -25.92 | -39.02 | 0.63 | -8.7 | -27.59 | 0.81 | 17.39 | 17.39 | 0.92 | -6.12 | 16.46 | 6.39 | 23.25 | 18.76 | 8.22 | 58.47 | 92.52 | 9.33 | 26.73 | 90.98 | 564 | 0.0 | 0.0 |
| 23Q4 (16) | 13.31 | -11.85 | -31.5 | 0.69 | -18.82 | -19.77 | 0.69 | -13.75 | -12.66 | 0.98 | 27.27 | 8.89 | 5.18 | -7.91 | 17.12 | 5.18 | -2.15 | 27.5 | 7.36 | 44.39 | 58.96 | 564 | 0.0 | 0.0 |
| 23Q3 (15) | 15.1 | -1.88 | -19.6 | 0.85 | -14.14 | -1.16 | 0.8 | -10.11 | 2.56 | 0.77 | -12.5 | -7.23 | 5.63 | -12.49 | 22.92 | 5.30 | -8.39 | 27.56 | 5.10 | -10.82 | 15.38 | 564 | 0.0 | 0.0 |
| 23Q2 (14) | 15.39 | -4.82 | 4.77 | 0.99 | 13.79 | 6.45 | 0.89 | 28.99 | 20.27 | 0.88 | 11.39 | 25.71 | 6.43 | 19.56 | 1.61 | 5.78 | 35.52 | 14.8 | 5.72 | 17.04 | 20.0 | 564 | 0.0 | 0.0 |
| 23Q1 (13) | 16.17 | -16.78 | 8.96 | 0.87 | 1.16 | 11.54 | 0.69 | -12.66 | -1.43 | 0.79 | -12.22 | 17.91 | 5.38 | 21.56 | 2.36 | 4.27 | 4.95 | -9.54 | 4.89 | 5.47 | 8.21 | 564 | 0.0 | 0.0 |
| 22Q4 (12) | 19.43 | 3.46 | 46.42 | 0.86 | 0.0 | 7.5 | 0.79 | 1.28 | -7.06 | 0.9 | 8.43 | 38.46 | 4.43 | -3.35 | -26.58 | 4.07 | -2.11 | -36.52 | 4.63 | 4.81 | -5.44 | 564 | 0.0 | 0.0 |
| 22Q3 (11) | 18.78 | 27.84 | 36.98 | 0.86 | -7.53 | 28.36 | 0.78 | 5.41 | -9.3 | 0.83 | 18.57 | 36.07 | 4.58 | -27.67 | -6.29 | 4.15 | -17.55 | -33.79 | 4.42 | -7.25 | -0.67 | 564 | 0.0 | 0.0 |
| 22Q2 (10) | 14.69 | -1.01 | -25.73 | 0.93 | 19.23 | 38.81 | 0.74 | 5.71 | -14.94 | 0.7 | 4.48 | 32.08 | 6.33 | 20.45 | 86.9 | 5.04 | 6.79 | 14.53 | 4.77 | 5.54 | 77.84 | 564 | 0.0 | 0.0 |
| 22Q1 (9) | 14.84 | 11.83 | 43.94 | 0.78 | -2.5 | 9.86 | 0.7 | -17.65 | -2.78 | 0.67 | 3.08 | 15.52 | 5.26 | -12.82 | -23.68 | 4.72 | -26.36 | -32.46 | 4.51 | -7.83 | -19.75 | 564 | 0.0 | 0.0 |
| 21Q4 (8) | 13.27 | -3.21 | 7.36 | 0.8 | 19.4 | 5.26 | 0.85 | -1.16 | 25.0 | 0.65 | 6.56 | 4.84 | 6.03 | 23.36 | -1.96 | 6.41 | 2.11 | 16.43 | 4.90 | 10.09 | -2.35 | 564 | 0.0 | 0.0 |
| 21Q3 (7) | 13.71 | -30.69 | 31.32 | 0.67 | 0.0 | -1.47 | 0.86 | -1.15 | 38.71 | 0.61 | 15.09 | -10.29 | 4.89 | 44.27 | -24.97 | 6.27 | 42.62 | 5.63 | 4.45 | 66.05 | -31.69 | 564 | 0.0 | 0.0 |
| 21Q2 (6) | 19.78 | 91.85 | 115.0 | 0.67 | -5.63 | 0.0 | 0.87 | 20.83 | 26.09 | 0.53 | -8.62 | -5.36 | 3.39 | -50.81 | -53.49 | 4.40 | -37.02 | -41.35 | 2.68 | -52.37 | -55.98 | 564 | 0.0 | 0.0 |
| 21Q1 (5) | 10.31 | -16.59 | -0.87 | 0.71 | -6.58 | -14.46 | 0.72 | 5.88 | 16.13 | 0.58 | -6.45 | -10.77 | 6.89 | 12.0 | -13.71 | 6.98 | 26.94 | 17.14 | 5.63 | 12.15 | -9.99 | 564 | 0.0 | 0.0 |
| 20Q4 (4) | 12.36 | 18.39 | 0.0 | 0.76 | 11.76 | 0.0 | 0.68 | 9.68 | 0.0 | 0.62 | -8.82 | 0.0 | 6.15 | -5.6 | 0.0 | 5.50 | -7.36 | 0.0 | 5.02 | -22.99 | 0.0 | 564 | 0.0 | 0.0 |
| 20Q3 (3) | 10.44 | 13.48 | 0.0 | 0.68 | 1.49 | 0.0 | 0.62 | -10.14 | 0.0 | 0.68 | 21.43 | 0.0 | 6.51 | -10.56 | 0.0 | 5.94 | -20.82 | 0.0 | 6.51 | 7.01 | 0.0 | 564 | 0.0 | 0.0 |
| 20Q2 (2) | 9.2 | -11.54 | 0.0 | 0.67 | -19.28 | 0.0 | 0.69 | 11.29 | 0.0 | 0.56 | -13.85 | 0.0 | 7.28 | -8.75 | 0.0 | 7.50 | 25.81 | 0.0 | 6.09 | -2.61 | 0.0 | 564 | 0.0 | 0.0 |
| 20Q1 (1) | 10.4 | 0.0 | 0.0 | 0.83 | 0.0 | 0.0 | 0.62 | 0.0 | 0.0 | 0.65 | 0.0 | 0.0 | 7.98 | 0.0 | 0.0 | 5.96 | 0.0 | 0.0 | 6.25 | 0.0 | 0.0 | 564 | 0.0 | 0.0 |
| 營收淨額 YoY | 推銷費用 YoY | 管理費用 YoY | 研發費 YoY | 推銷費用率(%) YoY | 管理費用率(%) YoY | 研發費用率(%) YoY | 員工人數 YoY | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 (10) | 51.8 | -13.62 | 3.68 | 8.55 | 3.39 | 10.78 | 3.51 | 2.63 | 7.10 | 25.68 | 6.54 | 28.26 | 6.78 | 18.82 | 564 | 0.0 |
| 2023 (9) | 59.97 | -11.48 | 3.39 | -0.88 | 3.06 | 1.32 | 3.42 | 10.32 | 5.65 | 11.98 | 5.10 | 14.47 | 5.70 | 24.63 | 564 | 0.0 |
| 2022 (8) | 67.75 | 18.71 | 3.42 | 20.42 | 3.02 | -8.48 | 3.1 | 30.8 | 5.05 | 1.44 | 4.46 | -22.91 | 4.58 | 10.18 | 564 | 0.0 |
| 2021 (7) | 57.07 | 34.63 | 2.84 | -3.4 | 3.3 | 26.44 | 2.37 | -5.2 | 4.98 | -28.25 | 5.78 | -6.09 | 4.15 | -29.59 | 564 | 0.0 |
| 2020 (6) | 42.39 | 10.39 | 2.94 | -13.27 | 2.61 | 16.0 | 2.5 | 1.63 | 6.94 | -21.44 | 6.16 | 5.08 | 5.90 | -7.94 | 564 | 0.0 |
| 2019 (5) | 38.4 | -2.27 | 3.39 | -6.35 | 2.25 | 7.66 | 2.46 | -5.38 | 8.83 | -4.18 | 5.86 | 10.15 | 6.41 | -3.19 | 564 | 0.0 |
| 2018 (4) | 39.29 | -11.97 | 3.62 | -12.35 | 2.09 | -8.33 | 2.6 | -1.52 | 9.21 | -0.44 | 5.32 | 4.13 | 6.62 | 11.87 | 564 | 0.0 |
| 2017 (3) | 44.63 | -7.54 | 4.13 | 12.23 | 2.28 | -14.29 | 2.64 | -11.11 | 9.25 | 21.38 | 5.11 | -7.29 | 5.92 | -3.86 | 564 | 0.0 |
| 2016 (2) | 48.27 | 13.15 | 3.68 | 7.92 | 2.66 | 26.67 | 2.97 | 3.85 | 7.62 | -4.62 | 5.51 | 11.95 | 6.15 | -8.22 | 564 | 0.0 |
| 2015 (1) | 42.66 | 13.22 | 3.41 | 6.9 | 2.1 | 12.3 | 2.86 | 12.6 | 7.99 | 0 | 4.92 | 0 | 6.70 | 0 | 564 | 0.0 |
